• Keine Ergebnisse gefunden

Smoking habits and risk of COVID‑19Marco Rossato

N/A
N/A
Protected

Academic year: 2022

Aktie "Smoking habits and risk of COVID‑19Marco Rossato"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Vol.:(0123456789)

1 3

Human Cell (2021) 34:1579

https://doi.org/10.1007/s13577-021-00559-3 LETTER TO THE EDITOR

Smoking habits and risk of COVID‑19

Marco Rossato

1

Received: 19 May 2021 / Accepted: 25 May 2021 / Published online: 16 June 2021

© Japan Human Cell Society 2021

Keywords Smoking · SARS-CoV-2 · COVID-19

Dear Editor,

I have read with interest the letter by Purhoit and Panda recently published in Human Cell, reporting the inverse rela- tionship between SARS-CoV-2 infection and current smok- ing in Indian population [1].

The results of the Authors are quite interesting, con- firming the observations coming from all around the world showing a quite low prevalence of active smokers among COVID-19 patients [2–4].

Recently, we have reported that among 132 Italian patients hospitalized in our COVID-hospital for SARS-CoV- 2-related pneumonia, no one was an active smoker, being patients never smokers or ex-smokers [5].

In their paper, the authors cited our previously published paper, but they reported that our data (coming from Italy) are in contrast with their observations. The opposite is true, since our previously published data completely agree with Authors’observations showing the absence of active smok- ers among hospitalized patients for SARS-CoV-2-related pneumonia.

References

1. Purhoit B, Panda AK. Smoking habits correlate with the defense against SARS-CoV-2 infection in the Indian population. Hum Cell. 2021. https:// doi. org/ 10. 1007/ s13577- 021- 00552-w. 2. Lee SC, Son KJ, Kim DW, et al. Smoking and the risk of severe

acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infec- tion. Nicotine Tob Res. 2021. https:// doi. org/ 10. 1093/ ntr/ ntab0 79.

3. Miyara M, Tubach F, Pourcher V, Morelot-Panzini C, Pernet J, Haroche J. Low rate of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios. 2020. https:// doi. org/ 10.

32388/ WPP19W.4.

4. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. 2020;15:845–52.

5. Rossato M, Russo L, Mazzocut S, Di Vincenzo A, Fioretto P, Vettor R. Current smoking is not associated with COVID-19. Eur Respir J. 2020;55:2001290.

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

* Marco Rossato marco.rossato@unipd.it

1 Clinica Medica 3, Department of Medicine–DIMED, University-Hospital of Padova, Via Giustiniani, 2, 35128 Padua, Italy

Referenzen

ÄHNLICHE DOKUMENTE

Infection of hMDM with HCoV-299E, MERS-CoV, SARS-CoV and SARS-CoV-2 at MOI of 1 TCID 50 /cell demonstrated high susceptibility to infection with the common cold virus HCoV-229E,

Our study provides new insight on the latter aspect for SARS-CoV by demonstrating that the SUD-N (Mac2) domain interacts with the host cell translation appa- ratus via Paip1

fraction, it improves on prior serologic studies assessment of asymptomatic cases. Serial testing

Here, we employed the human airway epithelial cell (hAEC) culture model to investigate the influence of different incubation temperatures on the viral replication kinetics and

Purpose To determine the prevalence of SARS-CoV-2 at a Danish tertiary referral otorhinolaryngology clinic during the first wave of the COVID-19 pandemic among patients

To support this hypothesis, we evaluated current literature on (1) The mechanism of SARS-CoV-2 infection and potential dietary inhibitors, (2) The younger age distribution of

With 84 customer contacts on average per employee and workday at the checkout counter, and with a SARS-CoV-2 prevalence of 3.59 %, 3 customers (3.02) are potential carriers of

›No health emergency in living memory has ever had greater repercussions for our health, economy and the way we live than the COVID-19 pandemic caused by SARS-CoV-2, commonly